News Detail

Basel, 30 Aug 2023: Roche has beaten competitors to score approval for the subcutaneous (SC) formulation of its blockbuster oncology drug, Tecentriq (atezolizumab).
Tecentriq SC was View Details
Source : Pharmaceutical Technolgy
Roche
subcutaneous (SC) formulation
oncology drug
Tecentriq (atezolizumab)
MHRA
approved by MHRA
Related News
- Ghaziabad: Fake Augmentin 625 Duo and Ultracet worth Rs 8 lakh seized, four arrested (24-09-2023)
- Police recovered 292 intoxicating capsules and 5760 pills in Ambala (24-09-2023)
- One Arrested by Cachar Police with 18,000 Yaba Tablets (24-09-2023)
- Indian-origin girl receives first rejection-free kidney from mother in UK (24-09-2023)
- 3D-printed medical devices gain ground (24-09-2023)
- Consignment of banned medicines seized in Rewari: Mother and son were running business (23-09-2023)
- 2 held with narcotic injections in Habsiguda (23-09-2023)
- Meghalaya CM’s ‘associate’ drug ‘kingpin’ was acquitted in 2018 (23-09-2023)
- Sriganganagar: Massive crackdown on drug traders, 14032 pills and capsules seized (23-09-2023)
- Action against three traders in Jamnagar city for selling duplicate beauty products (23-09-2023)